Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c03560 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Hsin-Yin Chuang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Missouri University of Science and Technology, Rolla, Missouri 65409, United States. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Dendrimers, Nanoparticles, Receptors, Urokinase Plasminogen Activator. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Missouri S&T Kummer Initiation Grant Initiative.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Missouri University of Science and Technology, Rolla, Missouri 65409, United States.
- Linda and Bipin Doshi Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, Missouri 65409, United States.
- College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China.
ORCID-Profile: Hsin-Yin Chuang, Da Huang, Yue-Wern Huang, Hu Yang
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Missouri S&T Kummer Initiation Grant Initiative
- Center for Biomedical Research (CBR) in S&T
- Ozark Biomedical Initiative
- John W. Claypool Fund for Medical Research
Zitieren
APA
Chuang, H. Y., Huang, D., Qi, L., Singh, V., Chernatynskaya, A., Huang, Y. W., & Yang, H. (2025). Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c03560
Vancouver
Chuang HY, Huang D, Qi L, Singh V, Chernatynskaya A, Huang YW, et al. Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c03560
BibTeX
@article{Chuang2025,
author = {Chuang, Hsin-Yin and Huang, Da and Qi, Lin and Singh, Vidit and Chernatynskaya, Anna and Huang, Yue-Wern and Yang, Hu},
title = {Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c03560}
}
EUVIMED